P
RINCETON, NJ--AxCell Biosciences, a wholly owned subsidiary of Cytogen, has entered into a partnership with Compaq to develop a database software package that the companies said will help select promising drug targets from protein pathway data generated by AxCell. The program will be facilitated by Compaq’s Alpha, high-performance, 64-bit systems to deliver speed and scalability advantages.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.